Issue 4/2009

The Role of PPARs in MDR – a lesson from embryonic development (279 — 283)

A. KONIECZNA, R. LICHNOVKA, B. ERDOSOVA, J. EHRMANN

DOI: 10.4149/neo_2009_04_279

Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression. (284 — 290)

A. HLOBILKOVA, J. EHRMANN, P. KNIZETOVA, V. KREJCI, O. KALITA, Z. KOLAR

DOI: 10.4149/neo_2009_04_284

Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer (291 — 297)

J. SUFLIARSKY, J. CHOVANEC, D. SVETLOVSKA, T. MINARIK, T. PACKAN, D. KROSLAKOVA, R. LALABOVA, L. HELPIANSKA, D. HORVATHOVA, L. SEVCIK, J. SPACEK, A. LALUHA, V. TKACOVA, V. MALEC, G. RAKICKA, D. MAGDIN, I. JANCOKOVA, A. DORR, M. STRESKO, V. HABETINEK, I. KOZA

DOI: 10.4149/neo_2009_04_291

Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract (298 — 302)

L. HYRSL, J. ZAVADA, Z. ZAVADOVA, I. KAWACIUK, S. VESELY, P.  SKAPA

DOI: 10.4149/neo_2009_04_29

Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy (303 — 316)

Z. KLEIBL, J. FIDLEROVA, P. KLEIBLOVA, S. KORMUNDA, M. BILEK, K. BOUSKOVA, J. SEVCIK, J. NOVOTNY

DOI: 10.4149/neo_2009_04_303

17β-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer (317 — 320)

Y. NAKAMURA, T. SUZUKI, Y. ARAI, H. SASANO

DOI: 10.4149/neo_2009_04_317

The design, synthesis and anticancer activity of new nitrogen mustard derivatives of natural indole phytoalexin 1-methoxyspirobrassinol (321 — 330)

R. MEZENCEV, P. KUTSCHY, A. SALAYOVA, T. UPDEGROVE, J. F. MCDONALD

DOI: 10.4149/neo_2009_04_321

Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma (331 — 334)

H. J. BAE, J. H. SONG, J. H. NOH, J. K. KIM, K. H. JUNG, J. W. EUN, H. J. XIE, J. C. RYU, Y. M. AHN, S. Y. KIM, S. H. LEE, N. J. YOO, J. Y. LEE, W. S. PARK, S. W. NAM

DOI: 10.4149/neo_2009_04_331

Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome (335 — 342)

A. VASIKOVA, E. BUDINSKA, M. BELICKOVA, J. CERMAK, H. BRUCHOVA

DOI: 10.4149/neo_2009_04_335

The Glu346Lys polymorphism and frameshift mutations of the Methyl-CpG Binding Domain 4 gene in gastrointestinal cancer (343 — 347)

J. H. SONG, E. J. MAENG, Z. CAO, S. Y. KIM, S. W. NAM, J. Y. LEE, W. S. PARK

DOI: 10.4149/neo_2009_04_343

TNF-α-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer (348 — 352)

M. M. STANKOVIC, A. R. NESTOROVIC, A. M. TOMOVIC, N. D. PETROVIC-STANOJEVIC, M. S. ANDJELIC-JELIC, V. B. DOPUDJA-PANTIC, LJ. M. NAGORNI-OBRADOVIC, M. M. MITIC-MILIKIC, D. P. RADOJKOVIC

DOI: 10.4149/neo_2009_04_348

Human exposure to polyhalogenated hydrocarbons and incidence of selected malignancies – central European experience (353 — 357)

V. BENCKO, J. RAMES, M. ONDRUSOVA, I. PLESKO, L. JURICKOVA, T. TRNOVEC

DOI: 10.4149/neo_2009_04_353

HSP27 diagnostic utility in the fine needle aspirate of breast. Correlation with progesterone and estrogen receptors (357 — 360)

J. MLYNARCZYK-LISZKA, B. MAKSYMIUK, D. PONIKIEWSKA, S. KRZYZOWSKA-GRUCA, D. LANGE, Z. KRAWCZYK, E. MALUSECKA

DOI: 10.4149/neo_2009_04_357

Mechanism of betulinic acid inhibition of collagen biosynthesis in human endometrial adenocarcinoma cells (361 — 366)

E. KARNA, J. A. PALKA

DOI: 10.4149/neo_2009_04_361